From: Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities
Neurosecretory factors | Receptors on tumor cells | Related pathways | Tumor changes |
---|---|---|---|
Acetylcholine | CHRM1 | EGFR/MAPK/PI3K/AKT [100] | Inhibits cancer progression, reduces inflammation |
CHRM1 (in stroma) [54] | Unspecified | Promotes prostate tumor growth and metastasis | |
CHRM3 | EGFR transactivation [101] | Promotes gastric cancer proliferation | |
NGF induction, cholinergic neuron growth [102] | Establishes tumor-nerve feedback loop | ||
CHRM4 | AKT [54] | Induces neuroendocrine differentiation and invasion | |
CHRNA5 | Ca2+/CaMKII/GSK-3β/β-catenin [43] | Enhances β-catenin, BDNF expression, metastasis, drug resistance | |
Catecholamines | ADRB2 | Promotes tumorigenesis in GIST | |
AKT/p53 [110] | Inhibits apoptosis, supports survival | ||
AKT/Beclin1/VPS34/HIF-1α [112] | Impairs autophagy, enhances resistance to stress | ||
ADRB3 | Promotes neuronal recruitment and tumor progression | ||
Epac/JNK/mTOR [113] | Stimulates ribosome biogenesis, cell cycle entry | ||
NGF | TrkA | MAPK/ERK [122] | Promotes tumor progression |
EphA2/SRC [57] | Promotes tumor progression | ||
HIF-1α [123] | Promote tumor new angiogenesis, promote tumor growth | ||
BDNF | TrkB | Promote cell proliferation, inhibit cell apoptosis and stimulate angiogenesis | |
Regulates cell proliferation, growth, size, metabolism, and movement | |||
PLC-γ/DAG [128] | Increase the survival rate of tumor cells and promote invasion | ||
Increase the survival rate of tumor cells and promote invasion | |||
p75 NTR | NF-κB/MMP9 [131] | Promote tumor cell survival and metastasis | |
AKT/ERK [132] | Promote tumor cell survival and metastasis | ||
Glutamate | NMDAR | Promotes invasion and metastasis via translational regulation of stress response proteins | |
Enhances glycolysis, supports perineural invasion | |||
AMPAR | Promotes invasion and migration in pancreatic cancer | ||
K-Ras/p38, K-Ras/p44/42[120] | Increases aggressiveness of precancerous lesions |